| 齐拉西酮与利培酮治疗精神分裂症对照研究 |
| |
| 引用本文： | 张述杰,王美娟,胡君,赵路平,郭影.齐拉西酮与利培酮治疗精神分裂症对照研究[J].中国民康医学,2008,20(17):2002-2003. |
| |
| 作者姓名： | 张述杰 王美娟 胡君 赵路平 郭影 |
| |
| 作者单位： | 沈阳精神卫生中心,辽宁沈阳,110168 |
| |
| 摘 要： | 目的：探讨齐拉西酮与利培酮治疗精神分裂症的疗效和安全性。方法：将60例精神分裂症患者随机分为齐拉西酮组和利培酮组，每组30例。疗程8周，采用阳性与阴性症状量表（PANSS）和治疗中出现的症状量表（TESS）评定疗效和不良反应。结果：齐拉西酮组有效率83．3％，显效率70．0％，利培酮组有效率86．7％，显效率73．3％。结论：齐拉西酮治疗精神分裂症疗效较好与利培酮相当，不良反应少。
|
| 关 键 词： | 齐拉西酮 利培酮 精神分裂症 |
Comparative analysis between ziprasidone and risperidone in teratment of schizophrenia |
| |
| ZHAMG Shu-jie,WANG Mei-juan,HU jun,et al.Comparative analysis between ziprasidone and risperidone in teratment of schizophrenia[J].medical journal of chinese peoples health,2008,20(17):2002-2003. |
| |
| Authors: | ZHAMG Shu-jie WANG Mei-juan HU jun |
| |
| Institution: | Shenyang Mental Health Center Shebyabg 110168 Liaoning |
| |
| Abstract: | Objective:To explore the efficacy and safety of ziprasidone in treatment of schizophrenia.Methods:60 patients with schizophreia were randomly assigned two groups ziprasidone group(n=30) and respenridone group(n=30) for 8 week.Positive and negative syndrome scale(PANSS) and treatment side effect scale(TESS)were used to evaluate the efficacy and side effects respectively.Results: The response rate and marked response rate was 83.3% and70.0% in ziprasidone treatment patients,and which was 86.7% and 73.3% in risperidone randomly patients.Conclusions: Ziprasidone has better treatment efficacy and less adverse effects in schizophrenia. |
| |
| Keywords: | Ziprasidone Resperidone Schizophrenia |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
